XLO - Financial Reports List - Xilio Therapeutics, Inc. - IntrinsicAlpha

Xilio Therapeutics, Inc. XLO

Healthcare - Biotechnology - NASDAQ - US

$ 0.815

8.44 %

$ 42.2 M

Market Cap

-0.75

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-40.59%	25.84%	24.83%
Annual Report	FY	10-K	2024-12-31	0.00%	23.77%	23.44%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	16.29%	14.97%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	28.05%	27.05%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	19.11%	29.70%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	18.88%	21.74%
Annual Report	FY	10-K	2023-12-31	0.00%	12.48%	11.24%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	13.55%	14.08%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	21.36%	18.07%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	1.00%	-10.85%

1